Medpace Holdings, Inc. logo
Medpace Holdings, Inc. (MEDP)
Compare

Medpace Holdings, Inc. (MEDP) Selling, General & Administrative Expenses

The sg&a expense for Medpace Holdings, Inc. (MEDP) is $197.56 Million with a year-over-year change of +9.64%. Selling, General & Administrative (SG&A) expenses include all costs related to selling products and running the business that are not directly tied to production.

MEDP SG&A Expense Chart

MEDP SG&A Expense
$197.56M+462.70% 20Y
Zoom

Current SG&A Expense

$197.56M

$197.56 Million

Year-over-Year Change

+9.64%

vs. $180.18M prior year

Historical Data

13

Years of data available

Annual SG&A Expense History

YearSG&A ExpenseYoY Change% Change
2025$197.56M+$17.38M+9.64%
2024$180.18M+$18.83M+11.67%
2023$161.35M+$29.95M+22.79%
2022$131.40M+$22.98M+21.19%
2021$108.42M+$16.27M+17.65%
2020$92.16M$-3.09M-3.24%
2019$95.25M+$19.56M+25.85%
2018$75.68M+$12.32M+19.45%
2017$63.36M+$1.85M+3.01%
2016$61.51M+$4.51M+7.91%
2015$57.00M+$17.33M+43.69%
2014$39.67M+$4.56M+12.99%
2013$35.11M
Data as of Thursday, June 18, 2026

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH
5,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle